UnitedHealth Denies DOJ Probe as WSJ Report Sparks 9% Stock Plunge

🗝️ Key Points

• Feb 21 – UnitedHealth (UNH, Financial) says the Wall Street Journal's report of a DOJ probe into its Medicare billing Practices is “misinformation” after market jitters.
• Analysts from RBC Capital Markets view the report as unsubstantiated, suggesting that any probe will likely follow a drawn-out process similar to last year's DOJ anti‑trust.
• Key business update or insight will appear here.

Feb 21 – UnitedHealth (UNH, Financial) says the Wall Street Journal’s report of a DOJ probe into its Medicare billing practices is “misinformation” after market jitters triggered an over 9% drop in its shares. The investigation allegedly targets how UnitedHealth records diagnoses to boost Medicare Advantage payments, including at its affiliated physician groups.

Following the WSJ report, UnitedHealth swiftly dismissed the claims, stressing that its Medicare Advantage program undergoes regular government reviews and that no new practices have been introduced. Analysts from RBC Capital Markets view the report as unsubstantiated, suggesting that any probe will likely follow a drawn-out process similar to last year’s DOJ anti‑trust investigation.

MORE IN INSIDE INVESTMENT NEWS

Intel’s stock has best day since 1987, soaring 24% as chipmaker shows signs of a turnaround

Published: Friday, April 24, 2026 · 8:24 PM

Outlook-proves-why-the-stock-deserves-a-spot-in-our-portfolio/" style="text-decoration: none; color: inherit;">

P&G’s solid quarter, confident outlook proves why the stock deserves a spot in our portfolio

Published: Friday, April 24, 2026 · 5:29 PM